Innovus Pharmaceuticals Inc (OTCMKTS:INNVD – Get Free Report) shot up 143.9% during mid-day trading on Monday . The company traded as high as $3.49 and last traded at $3.00. 4,300 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 9,592 shares. The stock had previously closed at $1.23.
Innovus Pharmaceuticals Trading Up 143.9 %
The firm’s 50-day simple moving average is $3.00. The company has a market cap of $7.07 million, a P/E ratio of -0.72 and a beta of 2.89.
Innovus Pharmaceuticals Company Profile
Innovus Pharmaceuticals, Inc, a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality.
Recommended Stories
- Five stocks we like better than Innovus Pharmaceuticals
- NYSE Stocks Give Investors a Variety of Quality Options
- Autodesk Stock: Analysts’ Top AI Pick You Shouldn’t Overlook
- What Does Downgrade Mean in Investing?
- Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss
- Why Invest in High-Yield Dividend Stocks?
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
Receive News & Ratings for Innovus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.